Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
16.19 USD | -2.41% | +16.14% | +56.88% |
May. 20 | Nurix Therapeutics Names New Board Chair | MT |
May. 14 | Stephens Initiates Nurix Therapeutics With Overweight Rating, $20 Price Target | MT |
Turnover - Change in analysts' estimates
Earnings Per Share (EPS) - Change in analysts' estimates
EBIT - Change in analysts' estimates
Cash or Net Debt - Change in analysts' estimates
Turnover
Earnings Per Share (EPS)
EBIT
Cash or Net Debt
- Stock Market
- Equities
- NRIX Stock
- Revisions Nurix Therapeutics, Inc.